Sangamo Therapeutics
SGMO
#9388
Rank
$91.76 M
Marketcap
$0.25
Share price
-19.66%
Change (1 day)
-62.59%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: $91.76 Million USD

As of April 2026 Sangamo Therapeutics has a market cap of $91.76 Million USD. This makes Sangamo Therapeutics the world's 9388th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026$91.76 M-35.83%
2025$0.14 B-73.23%
2024$0.53 B454.36%
2023$96.35 M-81.28%
2022$0.51 B-52.9%
2021$1.09 B-50.5%
2020$2.20 B127.38%
2019$0.97 B-17.26%
2018$1.17 B-15.37%
2017$1.38 B543.51%
2016$0.21 B-66.47%
2015$0.64 B-38.85%
2014$1.05 B21.5%
2013$0.86 B171.12%
2012$0.31 B113.99%
2011$0.14 B-50.54%
2010$0.30 B13.12%
2009$0.26 B86.78%
2008$0.14 B-72.83%
2007$0.52 B126.96%
2006$0.23 B87.74%
2005$0.12 B-18.75%
2004$0.15 B11.08%
2003$0.13 B83.3%
2002$74.46 M-67.43%
2001$0.22 B-47.05%
2000$0.43 B

End of Day market cap according to different sources

On Mar 31st, 2026 the market cap of Sangamo Therapeutics was reported to be:

$83.08 Million USD
by Nasdaq info icon info icon
$91.76 Million USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
$589.07 B 641,811.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$189.67 B 206,583.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$26.90 B 29,218.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
$29.97 B 32,560.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$172.98 B 188,402.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$297.40 B 323,979.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
$43.88 B 47,716.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$10.86 B 11,738.80%๐Ÿ‡บ๐Ÿ‡ธ USA